Abstract
Background. Org 25969 is a cyclodextrin compound designed to reverse a rocuronium-induced neuromuscular block. The aim of this study was to explore the efficacy, dose-response relation and safety of Org 25969 for reversal of a prolonged rocuronium-induced neuromuscular block.
Methods. Thirty anaesthetised adult patients received rocuronium 0.6mg kg as an initial dose followed by increments to maintain a deep block at level of
Original language | English |
---|---|
Pages (from-to) | 36-43 |
Number of pages | 8 |
Journal | British Journal of Anaesthesia |
Volume | 96 |
Issue number | 1 |
Publication status | Published - Jan 2006 |
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine